“More precision, less risk, faster drug development” ISAB CEO Lena Heffler on how clinical validation will power PreciseInhale®
Posted 28 maj 2019 in Okategoriserade
(Stockholm, 28 May, 2019) ISAB is making a major investment in validating its flagship aerosol R&D system for clinical use. Why is it such a vital step strategically?…
Read more